Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections.
Ibrahim TurkozMehmet DaskiranH Lynn StarrDean M NajarianOliver LopenaCamilo ObandoAlexander KeenanCarmela BensonSrihari GopalPublished in: Neuropsychiatric disease and treatment (2022)
In this analysis of Medicaid claims data, patients adequately treated with PP1M before transitioning to PP3M demonstrated significantly lower relapse rates and delayed time to relapse.